CLICLINYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank93
3Y CAGR-13.6%
5Y CAGR+11.1%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-13.6%/yr
vs +52.1%/yr prior
5Y CAGR
+11.1%/yr
Recent deceleration
Acceleration
-65.7pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
202586.64%+67.7%
202451.67%+93.3%
202026.73%-80.1%
2019134.29%+110.7%
201863.73%+24.6%
201751.16%-21.3%
201664.99%+158.8%
201525.12%-49.3%
201449.51%+10.0%
201345.02%-